Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Feldman, Candace H ^a   Hiraki, Linda T ^b   Lii, Huichuan ^a   Seeger, John D ^a   Kim, Seoyoung C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG UPTAKE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNIZATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; UNITED STATES; VACCINE FAILURE; AGE; CHRONIC DISEASE; INFLAMMATION; PATIENT ATTITUDE; RISK; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RISK; SEX FACTORS; YOUNG ADULT;

EID: 84923308685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117620     Document Type: Article

References (37)

1. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, et al. (2013) Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40:187-193. doi: 10.1097/OLQ.0b013e318286bb53 PMID: 23403598
2. Tam LS, Chan PK, Ho SC, Yu MM, Yim SF, et al. (2010) Natural history of cervical papilloma virus infection in systemic lupus erythematosus-a prospective cohort study. J Rheumatol 37:330-340. doi: 10.3899/jrheum.090644 PMID: 20032093
3. Rojo-Contreras W, Olivas-Flores EM, Gamez-Nava JI, Montoya-Fuentes H, Trujillo-Hernandez B, et al. (2012) Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis. Lupus 21:365-372. doi: 10.1177/0961203311425517 PMID: 22020266
4. Kim SC, Glynn RJ, Giovannucci E, Hernandez-Diaz S, Liu J, et al. (2014) Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis.
5. Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10:394-400. PMID: 11434573
6. Kane S, Khatibi B, Reddy D (2008) Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 103:631-636. PMID: 17941962
7. Markowitz LE, Dunn EF, Saraiya M, Chesson HW, Curtis CR, et al. (2014) Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR). Atlanta, GA: Centers for Disease Control and Prevention.
8. Prevention CfDCa (2013) Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007-2012, and Postlicensure Vaccine Safety Monitoring, 2006-2013-United States. Morbidity and Mortality Weekly Report (MMWR).
9. Lau M, Lin H, Flores G (2012) Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 30:3112-3118. doi: 10.1016/j.vaccine.2012.02.034 PMID: 22425179
10. Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103:164-169. doi: 10.2105/AJPH.2011.300600 PMID: 22698055
11. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, et al. (2011) Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 29:890-895. doi: 10.1016/j.vaccine.2009.12.063 PMID: 20056186
12. Heijstek MW, Scherpenisse M, Groot N, Tacke C, Schepp RM, et al. (2013) Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study. Ann Rheum Dis.
13. Mok CC, Ho LY, Fong LS, To CH (2013) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis 72:659-664. doi: 10.1136/annrheumdis-2012-201393 PMID: 22589375
14. Soldevilla HF, Briones SF, Navarra SV (2012) Systemic lupus erythematosus following HPV immunization or infection? Lupus 21:158-161. doi: 10.1177/0961203311429556 PMID: 22235047
15. Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, et al. (2012) Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med 271:193-203. doi: 10.1111/j.1365-2796.2011.02467.x PMID: 21973261
16. Arnheim-Dahlstrom L, Pasternak B, Svanstrom H, Sparen P, Hviid A (2013) Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 347:f5906. doi: 10.1136/bmj.f5906 PMID: 24108159
17. Malveaux FJ (2009) The state of childhood asthma: introduction. Pediatrics 123 Suppl 3:S129-130.
18. Blumenfeld Z, Lorber M, Yoffe N, Scharf Y (1994) Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus 3:59-61. PMID: 8025589
19. Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, et al. (1998) Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med 46:217-222. PMID: 9676054
20. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, et al. (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 95:1797-1800. PMID: 14652242
21. Lawrence JM, Black MH, Zhang JL, Slezak JM, Takhar HS, et al. (2014) Validation of pediatric diabetes case identification approaches for diagnosed cases by using information in the electronic health records of a large integrated managed health care organization. Am J Epidemiol 179:27-38. doi: 10.1093/aje/kwt230 PMID: 24100956
22. Krueger KP, Armstrong EP, Langley PC (2001) The accuracy of asthma and respiratory disease diagnostic codes in a managed care medical claims database. Disease Management 4:155-161.
23. Schluterman NH, Terplan M, Lydecker AD, Tracy JK (2011) Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 29:3767-3772. doi: 10.1016/j.vaccine.2011.03.032 PMID: 21440038
24. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA (2011) Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 127:77-84. doi: 10. 1542/peds.2010-0812 PMID: 21149425
25. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, et al. (2009) Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 18:1679-1686. doi: 10.1089/jwh.2008.1329 PMID: 19785564
26. Caskey R, Lindau ST, Alexander GC (2009) Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 45:453-462. doi: 10.1016/j. jadohealth.2009.04.021 PMID: 19837351
27. Rahman M, McGrath CJ, Berenson AB (2014) Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States. Vaccine 32:2394-2398. doi: 10.1016/j.vaccine.2014.02.097 PMID: 24637175
28. Rahman M, Laz TH, Berenson AB (2013) Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. Vaccine 31:5495-5499. doi: 10.1016/j.vaccine.2013.09.022 PMID: 24071591
29. Gudeman R (2007) High Cost of HPV Vaccine Limits Access in Surprising Way: The Problem with Private Insurance. Journal of the National Center for Youth Law 28:1-5.
30. Chao C, Velicer C, Slezak JM, Jacobsen SJ (2009) Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 84:864-870. doi: 10.1016/S0025-6196 (11) 60503-X PMID: 19797775
31. Avery RK (1999) Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 25:567-584, viii. PMID: 10467629
32. Kiefe CI, Funkhouser E, Fouad MN, May DS (1998) Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:357-365. PMID: 9669564
33. Yazdany J, Tonner C, Trupin L, Panopalis P, Gillis JZ, et al. (2010) Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther 12:R84. doi: 10.1186/ar3011 PMID: 20462444
34. Bernatsky SR, Cooper GS, Mill C, Ramsey-Goldman R, Clarke AE, et al. (2006) Cancer screening in patients with systemic lupus erythematosus. J Rheumatol 33:45-49. PMID: 16331804
35. Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, et al. (2007) The United States rheumatology workforce: supply and demand, 2005-2025. Arthritis Rheum 56:722-729. PMID: 17328042
36. Suris JC, Michaud PA, Akre C, Sawyer SM (2008) Health risk behaviors in adolescents with chronic conditions. Pediatrics 122:e1113-1118. doi: 10.1542/peds.2008-1479 PMID: 18977960
37. Dempsey A, Cohn L, Dalton V, Ruffin M (2011) Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 29:528-534. doi: 10.1016/j.vaccine.2010.10.051 PMID: 21050904